Evidence map›Paper›PMID 38441526›Full record

ArticleMicrobiology spectrum2024

Development and utilization of new O

Eva Agranier, Pauline Crétin, Aurélie Joublin-Delavat, Léa Veillard, Katia Touahri, François Delavat

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. The interplay between the marine diazotrophApplied and environmental microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eva AgranierNantes Université, CNRS, US2B, UMR6286, Nantes, France.
Pauline CrétinNantes Université, CNRS, US2B, UMR6286, Nantes, France.
Aurélie Joublin-DelavatNantes Université, CNRS, US2B, UMR6286, Nantes, France.
Léa VeillardNantes Université, CNRS, US2B, UMR6286, Nantes, France.
Katia TouahriNantes Université, CNRS, US2B, UMR6286, Nantes, France.
François DelavatNantes Université, CNRS, US2B, UMR6286, Nantes, France.ORCID 0000-0002-5985-4583
Centre National de la Recherche Scientifique · FR

Funding

Centre National de la Recherche Scientifique (CNRS) DBMCentre National de la Recherche Scientifique (CNRS) GdR OMER - MITIConseil Régional des Pays de la Loire (Région Pays de la Loire)
6 · The paper itself

Abstract

Fluorescent proteins have revolutionized science since their discovery in 1962. They have enabled imaging experiments to decipher the function of proteins, cells, and organisms, as well as gene regulation. Green fluorescent protein and all its derivatives are now standard tools in cell biology, immunology, molecular biology, and microbiology laboratories around the world. A common feature of these proteins is their dioxygen (O

Indexed as

BacteriaFlavinsVibrioGreen Fluorescent ProteinsOxygenFlavinsGreen Fluorescent ProteinsOxygenanaerobic conditionanoxiabioreporterflavin-binding fluorescent proteinRhizobiaceaeVibrio

Identifiers

PMID38441526
PMCPMC10986488
OpenAlexW4392449421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.